EMA Partners India IPO worth ₹76 crore is a combination of a fresh share sale of 53.34 lakh shares worth ₹66.14 crore and an offer for sale (OFS) of 7.96 lakh shares, totalling ₹9.87 crore.

IPO activity for companies backed by venture capital firms has stalled over the last three years, reaching its slowest level since 2011, according to a PitchBook report from Jan. 24. Now ...

Quick commerce company Zepto has completed a reverse flip from Singapore to India to become an Indian parent's entity ahead ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Denta Water & Infra Solutions IPO allotment status was declared today at around 4 PM, following a delay by the registrar. Denta Water & Infra IPO allotment was expected to be finalized by today ...

The company, which has been pushing its IPO plans for the past year, has been waiting to complete the integration of its acquired biosimilars firm Viatris and refinance debt before it goes public.

HistoSonics Inc., a medical device company whose backers include Johnson & Johnson’s venture capital arm, is weighing a US initial public offering as soon as this year, according to people ...

The IPO boom of 2024 is far from over. With 2,000 IPOs expected in the next two years (as per AIBI), India’s equity market is in overdrive. High-growth sectors like tech, e-commerce, and fintech ...

Laxmi Dental IPO allotment date is be in focus and the company is expected to finalise the basis of share allotment soon.(Image: Pixabay) Laxmi Dental IPO Allotment: The initial public offering ...

We built our IPO process in partnership with the investment banking community, ensuring that they have the control and information they need to successfully open your IPO. Nasdaq’s best-in-class ...

The Bay Area-based biotech revealed the planned IPO in a Jan. 7 filing with the Securities and Exchange Commission but did not divulge how many shares it plans to offer nor at what price.